About 2 800 reports

The Artificial intelligence/AI in drug discovery Market is projected to reach USD 4.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 45.7% during the forecast period. The growth of this market is primarily driven by factors such as the need to control drug discovery & development costs and reduce the overall time taken in this...

  • Artificial Intelligence
  • Drug Development
  • World
  • North America
  • Europe
  • APAC
  • Health Expenditure
  • Cancer Incidence

Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hyperalgesia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an...

  • Drug Development
  • World

The global Drug discovery services market is projected to reach USD 31.4 billion by 2026 from USD 16.1 billion in 2021, at a CAGR of 14.3% during the forecast period of 2021 to 2026. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing services, initiatives for research...

  • Drug Development
  • United States
  • World
  • North America
  • Europe
  • APAC
  • Pharmaceutical R&D Expenditure
  • Drug Approval

Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change provides the strategists; marketers and senior management with the critical information they need to assess the global artificial intelligence (AI) in drug discovery market as it emerges from the COVID 19 shut down. Description: Where...

  • Artificial Intelligence
  • Drug Development
  • World
  • APAC
  • Gross Domestic Product Per Capita
  • Pharmaceutical Production

A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the Drug Discovery Services Market,...

  • Drug Development
  • World
  • Latin America

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships Summary This report is the companion to Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion (July 2020).IT...

  • Infectious Disease
  • Drug Development
  • United States
  • World
  • Drug Approval
  • Manufacturing Output

Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Drugs In Development, 2022, provides an overview of the Achondroplasia (Musculoskeletal Disorders)...

  • Pharmaceutical
  • Drug Development
  • World
  • Drug Approval

5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor...

  • Pharmaceutical
  • Drug Development
  • Hormone
  • World
  • Drug Approval
  • Health Provider Density

Report Scope: In recent years, the drug discovery technologies industry has seen remarkable developments and rapid progress.This report focuses on the global drug discovery technologies market and provides an updated review to include basic design and its applications in different disease areas. The drug discovery...

  • Drug Development
  • World

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...

  • Drug Development
  • World

Oligodendroglioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma – Drugs In Development, 2022, provides an overview of the Oligodendroglioma (Oncology) pipeline...

  • Cancer
  • Targeted Therapy
  • Oncology
  • Therapy
  • Drug Development
  • World

Restenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an...

  • Drug Development
  • World
  • Prescription Drug Sales

Radiodermatitis - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Drugs In Development, 2021, provides an overview of the Radiodermatitis (Toxicology) pipeline landscape. Radiodermatitis is an inflammation of the skin caused...

  • Dermatological Condition
  • Drug Development
  • World
  • Hospital Occupancy Rate
  • Drug Approval

This IDC Perspective provides deep insight into the crucial role of GPU-powered transformer models in accelerating innovation and designing new therapies. This is the era of a data-driven drug discovery and development. New deep learning models are replacing the conventional strategy of knocking down gene expression using small interfering...

  • Drug Development
  • Transformer
  • World

Retinitis Pigmentosa (Retinitis) (Ophthalmology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) – Drugs In Development, 2021, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline...

  • Drug Development
  • World
  • China
  • South Africa
  • Drug Approval
  • Medicine Use

Rett Syndrome (Central Nervous System) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome - Drugs In Development, 2021, provides an overview of the Rett Syndrome (Central Nervous System) pipeline landscape. Rett syndrome is a...

  • Neurological Disorder
  • Drug Development
  • World
  • Health Provider Density
  • Drug Approval

Toxoplasmosis (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis – Drugs In Development, 2021, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape. Toxoplasmosis is a disease...

  • Infectious Disease
  • Drug Development
  • World
  • Health Provider Density

5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin receptor 2B is a protein encoded by the HTR2B gene. It plays a role in the regulation of behavior,...

  • Pharmaceutical
  • Drug Development
  • Hormone
  • World

The Live Cell Imaging market is projected to register a CAGR of 7.37% during the forecast period with market size of USD 1,802.18 million in 2021 and expected to reach USD 2,775.88 million by 2027. The COVID-19 pandemic had a severe impact on the market as there were supply chain disruptions due to lockdown. However, the increasing...

  • Chronic Disease
  • Drug Development
  • Microscope
  • Molecular Biology
  • World
  • Chronic Disease Prevalence
  • Cancer Incidence

Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data on the effectiveness of the investigation of medical products contribute to their low success rate.Digital...

  • Clinical Trial
  • Biomarker

Hyperinsulinemia (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hyperinsulinemia – Drugs In Development, 2021, provides an overview of the Hyperinsulinemia (Metabolic Disorders) pipeline landscape. Hyperinsulinemia...

  • Drug Development
  • World
  • Pharmaceutical Registrations
  • Diabetes Prevalence

Osteomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Osteomyelitis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides...

  • Pharmaceutical
  • Therapy
  • Drug Development
  • World
  • Diabetes Prevalence

Pulmonary Embolism (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Embolism (Cardiovascular) - Drugs In Development, 2021, provides an overview of the Pulmonary Embolism (Cardiovascular) pipeline landscape. Pulmonary...

  • Cardiovascular Disease
  • Blood Disease
  • Compression Therapy
  • Drug Development
  • World
  • South Korea
  • Pharmaceutical Registrations

Graves Diseases (Hormonal Disorders) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Drugs In Development, 2021, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape. Graves’ disease is an...

  • Drug Development
  • World
  • Mortality Rate
  • Drug Approval

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Drugs In Development, 2021, provides an overview of the Dermatomyositis (Musculoskeletal Disorders) pipeline landscape.Dermatomyositis is a rare...

  • Neurological Disorder
  • Drug Development
  • World
  • South Africa
  • Pharmaceutical Registrations
  • Drug Approval

Fragile X Syndrome (Genitourinary Disorders) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fragile X Syndrome - Drugs In Development, 2021, provides an overview of the Fragile X Syndrome (Genetic Disorders) pipeline landscape. Fragile...

  • Drug Development
  • World
  • South Africa
  • Health Provider Density
  • Pharmaceutical Registrations

Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Nocturia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview...

  • Drug Development
  • World

Presbyopia (Ophthalmology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Presbyopia – Drugs In Development, 2021, provides an overview of the Presbyopia (Ophthalmology) pipeline landscape. Presbyopia is an eye condition in which eye slowly...

  • Ophthalmology
  • Drug Development
  • World
  • Drug Approval
  • Pharmaceutical Registrations

Hypereosinophilic Syndrome (Hematology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypereosinophilic Syndrome - Drugs In Development, 2021, provides an overview of the Hypereosinophilic Syndrome (Hematological Disorders) pipeline landscape.The...

  • Drug Development
  • World
  • Pharmaceutical Registrations
  • Drug Approval

The global liquid handling systems market is expected to reach USD 5.1 billion by 2026 from USD 4.0 billion in 2021, at a CAGR of 5.1% during the forecast period. The growth of this market is majorly driven by industrial growth in the pharma-biotech sector, rising R&D expenditure by biopharma companies, and growing life science research, supported...

  • Drug Development
  • World
  • North America
  • Europe
  • United States
  • Asia
  • Chronic Disease Prevalence
  • Infectious Disease Mortality